About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 943520, 6 pages
http://dx.doi.org/10.1155/2013/943520
Research Article

In Vitro Antiophidian Mechanisms of Hypericum brasiliense Choisy Standardized Extract: Quercetin-Dependent Neuroprotection

1CIPBIOTEC, Federal University of Pampa, (UNIPAMPA), Campus São Gabriel, 97300-000 São Gabriel, RS, Brazil
2Laboratory of Natural Products Technology, Federal University Fluminense, Faculty of Pharmacy, 24241-002 Niterói, RJ, Brazil
3Federal Institute of Espírito Santo, Campus Vila Velha, 29106-010 Vila Velha, Espírito Santo, Brazil
4LAQUIP, Department of Biochemistry, Institute of Biology, State University of Campinas (UNICAMP), P.O. Box 6109, 13083-970 Campinas, SP, Brazil
5Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), P.O. Box 6111, 13083-970 Campinas, SP, Brazil

Received 20 September 2013; Accepted 4 December 2013

Academic Editor: Marina Soković

Copyright © 2013 Cháriston André Dal Belo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The neuroprotection induced by Hypericum brasiliense Choisy extract (HBE) and its main active polyphenol compound quercetin, against Crotalus durissus terrificus (Cdt) venom and crotoxin and crotamine, was enquired at both central and peripheral mammal nervous system. Cdt venom (10 μg/mL) or crotoxin (1 μg/mL) incubated at mouse phrenic nerve-diaphragm preparation (PND) induced an irreversible and complete neuromuscular blockade, respectively. Crotamine (1 μg/mL) only induced an increase of muscle strength at PND preparations. At mouse brain slices, Cdt venom (1, 5, and 10 μg/mL) decreased cell viability. HBE (100 μg/mL) inhibited significantly the facilitatory action of crotamine (1 μg/mL) and was partially active against the neuromuscular blockade of crotoxin (1 μg/mL) (data not shown). Quercetin (10 μg/mL) mimicked the neuromuscular protection of HBE (100 μg/mL), by inhibiting almost completely the neurotoxic effect induced by crotoxin (1 μg/mL) and crotamine (1 μg/mL). HBE (100 μg/mL) and quercetin (10 μg/mL) also increased cell viability in mice brain slices. Quercetin (10 μg/mL) was more effective than HBE (100 μg/mL) in counteracting the cell lysis induced by Cdt venom (1 and 10 μg/mL, resp.). These results and a further phytochemical and toxicological investigations could open new perspectives towards therapeutic use of Hypericum brasiliense standardized extract and quercetin, especially to counteract the neurotoxic effect induced by snake neurotoxic venoms.

1. Introduction

An estimated 5.4-5.5 million people are bitten by snakes each year, resulting in about 400.000 amputations and about 125.000 deaths [1, 2]. The problem of human suffering by snake bite is actually so relevant that WHO has included it in the list of neglected tropical diseases in April, 2009 [3].

Snake venoms embody a complex mixture of toxic enzymes and proteins, such as myotoxins, neurotoxins, cytotoxins, hemorrhagic metalloproteases, clotting serineproteases, and others [4]. Among all snake venoms, the crotalic is one of the most neurotoxic, in which systemic effects reside primarily in the peripheral neurotoxicity. However, when injected directly on CNS of mammals it can induce convulsion and death [5]. Among other symptoms, the neurotoxicity induced by Crotalus poisoning in both central and peripheral nervous system is mainly related to the presence in the venom of the toxins crotoxin [6] and crotamine [7]. Thus, the search of novel venom inhibitors is therefore relevant, being natural or synthetic, in order to complement the current serum therapy and to neutralize the remaining damages of snake envenomation.

Hypericum brasiliense is an annual cycle plant, recurrent in the southern and southeastern Brazil, known by the common names of “milfurada”, “milfacadas,” and “alecrim bravo” [8, 9]. H. brasiliense extract has shown anti-inflammatory and analgesic [10] activities, with contradictory signs on the CNS [11] and protection of mice against lethality of Bothrops jararaca venom [12].

The present work demonstrates the ability of Hypericum brasiliense standardized extract and quercetin to counteract neurodegenerative insults induced by Cdt venom in brain and muscles preparations. In addition, it is shown that the major neurotoxic components of the Crotalus durissus terrificus venom, crotoxin and crotamine, also had their effects prevented in the neuromuscular paralysis at mouse nerve-muscle preparations.

2. Experimental

2.1. Reagents and Venom

All chemicals and reagents used were of the highest purity and were obtained from Sigma, Aldrich, Merck or BioRad. Crotalus durissus terrificus venom, crotamine and crotoxin were donated by Dr. S. Marangoni (UNICAMP) and quercetin by Dr. L. Rocha (UFF).

2.2. Animals

Adult Swiss white mice (28–35 g) from both sexes were supplied by the Multidisciplinary Center for Biological Investigation (CEMIB) at UNICAMP and by the animal facility from Universidade Federal de Santa Maria (UFSM). The animals were housed at 25°C with access ad libitum to food and water. These studies have been done in accordance with the guidelines of the Brazilian College for Animal Experimentation (COBEA).

2.3. Plant Material

Hypericum brasiliense leaves were collected in the city of Nova Friburgo, RJ, Brazil, in 2001. A voucher specimen (n°19980) has been deposited at the herbarium of the Museu Nacional, Universidade Federal do Rio de Janeiro, Brazil.

2.4. Chemical Analysis

The preparation of H. brasiliense EtOH extract (HBE) and detection of its chemical composition were carried out as described elsewhere [13]. Briefly, the chemical analysis was performed with a Liquid Chromatograph (GBC Scientific Equipment LLC, Hampshire, IL, USA), equipped with a Nucleosil MN 120-5 C18 silica column (Macherey-Nagel Inc., Bethelehem, PA, USA). The elution was made at room temperature using a linear gradient from 10–60% of acetonitrile in trifluoroacetic acid (0.05% v/v) at a flow rate of 1.0 mL/min in 30 minutes. Peaks were monitored at 254 nm in order to quantify the flavonoid quercetin.

2.5. Hippocampal Slices Preparation

Mice were decapitated, the brains removed immediately, and the hippocampus dissected on ice and humidified in cold HEPES-saline buffer gassed with O2 (124 mm NaCl, 4 mM KCl, 1.2 mM MgSO4, 12 mM glucose, 1 mM CaCl2, and 25 mM HEPES pH 7.4). Hippocampal slices were obtained according to Vinadé & Rodnight [14], briefly: a Mcilwain tissue chopper was used to obtain the slices (0.4 mm) that were separated and preincubated at 37°C for 30 min in microwell plates filled with HEPES saline (200 μL/slice). Subsequently, fresh medium was replaced (200 μL/slice) for control condition and treatments with Cdt (1, 5 and 10 μg/mL), HBE (100 μg/mL), HBE + Cdt, quercetin (10 μg/mL), and quercetin + Cdt and incubated for 1 hour (37°C).

2.6. Hippocampal Slices Viability

Immediately after incubation with treatments, slices were assayed for a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test (0.05% in HEPES-saline) for 30 min (37°C) [15]. The MTT is converted into a purple formazan product after cleavage of the tetrazolium ring by mitochondrial dehydrogenases. Formazan was dissolved by the addition of DMSO, resulting in a colored compound whose optical density (  nm) was measured in an ELISA reader equipment [16].

2.7. Phrenic Nerve-Diaphragm Preparation

Whole diaphragms along with the phrenic nerves were removed from mice killed by carbon dioxide (CO2) and exsanguinated. Both hemidiaphragms were mounted essentially as described for dal Belo et al. [17]. The preparations were suspended under a constant tension of 5 g in a 5 mL organ bath containing aerated (95%O2–5%CO2) Tyrode solution (pH 7.4, 37°C) of the following composition (mM): NaCl 137, KCl 2.70, CaCl2 1.80, MgCl2 0.490, NaH2PO4 0.420, NaHCO3 11.9, and glucose 11.1. Supramaximal stimuli (0.1 Hz, 0.2 ms) delivered by a Grass S4 electronic stimulator (Grass Instrument Co., Quincy, MA, USA) were applied through electrodes placed around the motor nerve, corresponding to an indirect stimulation.

2.8. Statistical Analysis

The results were expressed as the mean ± SEM and were compared statistically using ANOVA for repeated measures. A   value 0.05 indicated significance.

3. Results

HBE was shown to be rich in flavonoids derivatives such as kaempferol, quercetin, and quercetin glycosides (quercitrin, isoquercitrin, guaijaverin, and hyperoside) [13]. The selective extraction of polyphenol compounds in HBE resulted, after hydrolysis, in not less than 6,7% of total flavonoids, expressed as quercetin. Incubation of mouse phrenic nerve-diaphragm preparation (PND) with Tyrode solution did not induce alterations in basal muscle twitch tension during 120 min recordings ( , Figure 1). When Crotalus durissus terrificus venom (Cdt, 10 μg/mL) was added to (PND) preparation there was an increase of 160% in the muscle twitch tension followed by an irreversible and complete neuromuscular blockade after 70 min ( , Figure 1). Incubation of PND preparation with HBE (10 and 100 μg/mL) produced no alteration in the amplitude of muscle twitch tension ( ), during 120 min observation. However, when preparations were assayed with a mixture of HBE (50 μg/mL and 100 μg/mL) and Cdt venom (10 μg/mL) previously incubated during 30 min at 37°C, the characteristic neuromuscular blockade was prevented in 75% with the highest concentration of the extract (Figure 1(a), , ). The assay of the myotoxin crotamine (1 μg/mL) alone at PND preparations induced a significative increase of muscle twitch tension (~150%), that was maximum at 30 min ( , , Figure 1(b)). On the contrary, the addition of the PLA2 neurotoxin crotoxin isolated (1 μg/mL) at PND preparations caused a progressive and irreversible neuromuscular blockade during 120 min recordings ( , ). The assay of HBE (100 μg/mL) + crotamine (1 μg/mL) or crotoxin (1 μg/mL), previously incubated for 30 min at 37°C, inhibited 100% of the facilitatory actions induced by crotamine and 85% of the neuromuscular blockade caused by crotoxin (1 μg/mL), respectively, in 120 min recordings ( , , data not shown). When quercetin (10 μg/mL) was incubated alone, there was a maximum decrease of muscle twitch tension of % in 120 min recordings, although not significative (Figure 1(b), compared to the control Tyrode). The addition of quercetin (10 μg/mL) with crotamine (1 μg/mL) or crotoxin (1 μg/mL) previously incubated for 30 min at 37°C showed a more potent antineurotoxic activity when compared to the HBE. This increased potency of quercetin compared to HBE must be due to a higher effective concentration of the flavonoid when compared to the whole extract (~7%). Quercetin was able to completely inhibit the facilitatory actions of crotamine (1 μg/mL) and decreased in % the neuromuscular blockade induced by crotoxin (1 μg/mL) ( , , Figure 1(b)).

fig1
Figure 1: Neutralizing activity of H. brasiliense ethanolic plant extract (HBE) against Crotalic venom, crotoxin and crotamine at mouse phrenic nerve-diaphragm preparations. Panel (a) shows the inhibitory effect of HBE (10 and 100 μg/mL) against C. d. terrificus venom (10 μg/mL), crotoxin and crotamine. In Panel (b) effect of Quercetin (10 and 100 μg/mL) against Cdt (10 μg/mL), crotoxin (1 μg/mL), and crotamine (1 μg/mL). When HBE was applied alone in the organ-bath no alteration in the twitch-tension was observed. On both graphs control Tyrode solution lines show no alteration of normal nerve-muscle activity. The points on the graphs represent the mean ± S.E.M. of five experiments. On (b) note that quercetin mimicked the protective effect induced by HBE. HBE: Hypericum brasiliense standardized extract * compared to control Tyrode.

The effect of HBE (100 μg/mL) or quercetin (10 μg/mL) alone was accessed at central nervous system (CNS) through hippocampal slices. In this set of experiments the cell viability was not modified after 1 h incubation with both vegetal extract and the pure flavonoid. On the other hand, the incubation of Cdt venom in doses of (1, 5, and 10 μg/mL) significantly decreased the cell viability ( , and %, , , resp.) (Figures 2(a) and 2(b)). The addition of HBE (100 μg/mL) with Cdt (10 μg/mL) to the slices produced a slight protection compared to the control Cdt ( , ) (Figure 2(a)). However, the blend of quercetin (10 μg/mL) and Cdt (1 μg/mL or 5 μg/mL), significantly inhibited the cell lysis showing a protection in the order of % and %, , , respectively (Figure 2(b)). The results in hippocampal slices confirm the HBE and quercetin potential role in the neuroprotection against Cdt poisoning. Therefore, the difference in potency between HBE and quercetin must also be related to the less amount of the flavonoid in the extract.

fig2
Figure 2: Effects of Cdt on the viability of hippocampal slices. (a) Hippocampal slices were incubated with HBE (100 μg/mL) in the presence or absence of Cdt (10 μg/mL) during 1 hour. (b) Hippocampal slices were incubated during 1 hour with Quercetin (10 μg/mL) in the presence or absence of Cdt (1 and 5 μg/mL). Cell viability was measured by MTT test. Values are expressed as % of control, which was defined as untreated slices (values are means ± S.E.M., ). On (b) note that quercetin mimicked the HBE protective activity. HBE: Hypericum brasiliense standardized extract** compared to control*.

4. Discussion

In this work we described for the first time the effectiveness of the H. brasiliense extract (HBE) and its marked compound quercetin, against the neuromuscular paralysis induced by Crotalus durissus terrificus snake venom (Cdt), crotoxin, and crotamine at mouse phrenic nerve-diaphragm preparations. Also, the effectiveness of HBE and quercetin was validated, to counteract the deleterious effects induced by C. d. terrificus venom, on cell viability of mouse brain slices. Crotalus venom induces neurotoxicity, coagulation disorders, systemic myotoxicity, and acute renal failure [18], with possible additional heart and liver damage [19]. This venom is a mixture of enzymes, toxins (crotoxin, crotamine, gyroxin, and convulxin), and several other peptides [19]. The characteristic pathophysiological pictures of neurotoxicity and systemic myotoxicity associated with C. d. terrificus envenomation are mainly related to the presence in the venom of crotoxin, a neurotoxic PLA2 heterodimeric complex, which causes progressive paralysis, and in high concentrations myonecrosis [20, 21]. At nerve terminals, crotoxin induces triphasic alterations in the mean quantal content of transmitter release with a slow and progressive decrease of presynaptic release of the neurotransmitter acetylcholine that results in complete neuromuscular blockade [22, 23]. At mammal central nervous system, the injection of Cdt venom induces seizures [5], which is mainly associated with the presence of crotoxin [24]. At brain synaptosomes, crotoxin has also shown the ability of inhibiting L-glutamate and gamma aminobutyric acid (GABA) uptake [25]. Crotamine is the second major toxin in the Cdt venom; it is a basic, low molecular weight myotoxin devoid of PLA2 activity [26], with a specific action on voltage-sensitive sodium channels of muscles [27] and brain cells [28].

Flavonoids are plant secondary metabolites that embrace a wealth of possibilities of hydrogen bonding arranged around a relatively small carbon skeleton, capable of interacting with molecular targets [29]. In the H. brasiliense extract, the flavonoid quercetin and its derivatives were shown to be the major secondary metabolites in the plant. Quercetin and several of its glycosides are the most often encountered flavonoids in anti-snake venom plants where Albizia lebbeck, Achillea millefolium, Euphorbia hirta, Camellia sinensis, and Casearia sylvestris are some examples. Flavonoids have been reported as snake venom phospholipase A2 inhibitors [30].

Recent studies revealed that the treatment of the snake venom PLA2 isoform from Crotalus durissus cascavella snake venom with the flavonoid quercetin produced a decrease in the pharmacological activity of the neurotoxin by inducing alterations in the secondary but not in tertiary structure composition of the molecule [31]. As discussed above, flavonoids have the ability of binding to biological polymers (e.g., enzyme inhibiting activities). Therefore, snake PLA2 catalyzed the production of lysophospholipids and fatty acids that are involved in membrane damage [21]. We suggest that, in the case where biological activity is enzyme-dependent, the HBE antineurotoxic activity would involve the inactivation of PLA2 activity by quercetin. However, the possibility that the HBE acts through a mechanistic intervention rather than an in vitro direct physical interaction with the venom is also a reasonable idea. This is likely to be the mode of action of many polyphenolic compounds found in plant extracts, which probably explains many of the “protective” effects of plant extracts when they are preincubated with venom before administration to the biological assay [32, 33].

Flavonoids derived from plants or tea extracts also affect acetylcholine release, muscle contraction, or neuromuscular junction activity [34]. In this regard, the muscle-type nicotinic acetylcholine receptor consists of α1β1ε, in adult tissue [35]. It was found that quercetin inhibits the muscle type nicotinic acetylcholine receptor, by binding on the γ or ε subunities, which is a characteristic of a noncompetitive inhibitor [36]. Crotoxin also stabilizes the postsynaptic membrane of Torpedo marmorata by binding in non-ACh biding sites [37]. Hence, these similarities in terms of binding sites would strengthen the hypothesis of a site-direct antagonism between quercetin and crotoxin at nerve terminals. In addition, quercetin actively participates in intracellular signaling, inhibiting phosphatidylinositol-3 kinase, protein kinase C, xanthine oxidase, and NADPH diaphorase [34]. In massive cellular insults like ischemia, involving metabolic failure, loss of Ca2+ homeostasis, and excitotoxicity, scavenger activity or one-target antioxidant mechanisms (NMDA receptor blockers, chain-breaking vitamin E, or pure scavenger molecules such as boldine) may fail to protect cells from free radical damage. Current explanation for the neuroprotective effect of quercetin is its antioxidant capacity and its ability to scavenge free radicals [34]. At moment there is no evidence that snake venoms induce cellular insults to increase free radicals in nerve terminals. However, the actions of Cdt venom on cell viability of brain slices is likely to be devoid to the presence of crotoxin and crotamine that ultimately account for the increase of excitatory neurotransmitters [22], resulting in excitotoxicity [38]. The decrease in neurotransmitter uptake by crotoxin is calcium independent [25], and quercetin potentiates neuronal excitability by increasing neuronal firing rates [39]. Ultimately, excitotoxicity is a result of synaptic dysfunction processes, which involves the excessive glutamate receptor activation and neuronal degeneration [38]. Based on the above considerations we suggest that the mechanism of the benefit of quercetin on snake venom-induced neuronal cellular death is complex and beyond the inhibition of presynaptic activity of snake PLA2, and structural modifications, which may affect neurotransmitter uptake, involve the maintenance of neuronal mitochondrial transmembrane electric potential which would decrease the overstimulation of glutamate receptors [34]. However, in the case of crotamine, a direct inhibition of voltage-gated sodium channels by quercetin seems to be a coherent explanation [40].

Further investigation on Hypericum brasiliense isolated compounds will strengthen the understanding of its antiophidian activity. Preclinical assays, including safety assessment protocols, could also open the way towards therapeutic use of Hypericum brasiliense especially when neurotoxic venoms are involved.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

The authors thank Gildo Bernardo Leite for the excellence in technical assistance with mouse phrenic nerve-diaphragm preparations. Dr. Thais Posser for kind loan of MTT. This work was supported by Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundo de Apoio ao Ensino, à Pesquisa e Extensão (FAEPEX), and Coordenação de Aperfeiçoamento de Pessoal de nível Superior-CAPES Edital Toxinologia 063/2010.

References

  1. A. Kasturiratne, A. R. Wickremasinghe, N. de Silva et al., “The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths,” PLoS Medicine, vol. 5, no. 11, article e218, pp. 1591–1604, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Boldrini-França, C. Corrêa-Netto, M. M. S. Silva et al., “Snake venomics and antivenomics of Crotalus durissus subspecies from Brazil: assessment of geographic variation and its implication on snakebite management,” Journal of Proteomics, vol. 73, no. 9, pp. 1758–1776, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Williams, J. M. Gutiérrez, R. Harrison et al., “The Global Snake Bite Initiative: an antidote for snake bite,” The Lancet, vol. 375, no. 9708, pp. 89–91, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Soares, F. K. Ticli, S. Marcussi et al., “Medicinal plants with inhibitory properties against snake venoms,” Current Medicinal Chemistry, vol. 12, no. 22, pp. 2625–2641, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. L. E. A. M. Mello and E. A. Cavalheiro, “Behavioural, electroencephalographic and neuropathological effects of the intrahippocampal injection of the venom of the South American rattlesnake (Crotalus durissus terrificus),” Toxicon, vol. 27, no. 2, pp. 189–199, 1989. View at Scopus
  6. O. V. Brazil, “Pharmacology of crystalline crotoxin. II. Neuromuscular blocking action,” Memorias do Instituto Butantan, vol. 33, no. 3, pp. 981–992, 1966. View at Scopus
  7. C. C. Chang and K. H. Tseng, “Effect of crotamine, a toxin of South American rattlesnake venom, on the sodium channel of murine skeletal muscle,” British Journal of Pharmacology, vol. 63, no. 3, pp. 551–559, 1978. View at Scopus
  8. C. R. Jimenez, “Hipericaceas,” R. Reitz, Ed., Flora Ilustrada Catarinense I Parte: As Plantas, pp. 23–27, Itajaı, 1980.
  9. M. P. Correa, Dicionário das Plantas Uteis do Brasil e das Exóticas Cultivadas—Vol. I, Ministerio da Agricultura y Instituto Brasileiro de Desenvolvimento Florestal, Brasília, Brazil, 1984.
  10. F. F. Perazzo, L. M. Lima, M. D. M. Padilha, L. M. Rocha, P. J. C. Sousa, and J. C. T. Carvalho, “Anti-inflammatory and analgesic activities of Hypericum brasiliense (Willd) standardized extract,” Brazilian Journal of Pharmacognosy, vol. 18, no. 3, pp. 320–325, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Rieli Mendes, R. Mattei, and E. L. de Araújo Carlini, “Activity of Hypericum brasiliense and Hypericum cordatum on the central nervous system in rodents,” Fitoterapia, vol. 73, no. 6, pp. 462–471, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Rocha, M. A. C. Kaplan, B. M. Ruppelt, and N. A. Pereira, “Atividade biológica de Hypericum brasiliense,” Revista Brasileira de Fármacia, vol. 72, no. 3, pp. 67–69, 1991.
  13. L. Rocha, A. Marston, O. Potterat, M. A. Kaplan, H. Stoeckli-Evans, and K. Hostettmann, “Antibacterial phloroglucinols and flavonoids from Hypericum brasiliense,” Phytochemistry, vol. 40, no. 5, pp. 1447–1452, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Vinadé and R. Rodnight, “The dephosphorylation of glial fibrillary acidic protein (GFAP) in the immature rat hippocampus is catalyzed mainly by a type 1 protein phosphatase,” Brain Research, vol. 732, no. 1-2, pp. 195–200, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. F. M. Cordova, A. L. S. Rodrigues, M. B. O. Giacomelli et al., “Lead stimulates ERK1/2 and p38MAPK phosphorylation in the hippocampus of immature rats,” Brain Research, vol. 998, no. 1, pp. 65–72, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Liu, D. A. Peterson, H. Kimura, and D. Schubert, “Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) reduction,” Journal of Neurochemistry, vol. 69, no. 2, pp. 581–593, 1997. View at Scopus
  17. C. A. dal Belo, A. V. Colares, G. B. Leite et al., “Antineurotoxic activity of Galactia glaucescens against Crotalus durissus terrificus venom,” Fitoterapia, vol. 79, no. 5, pp. 378–380, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Sitprija and N. Chaiyabutr, “Nephrotoxicity in snake envenomation,” Journal of Natural Toxins, vol. 8, no. 2, pp. 271–277, 1999. View at Scopus
  19. B. Barraviera, B. Lamonte, A. Tarkowski, L. A. Hanson, and D. Meira, “Acute phase reactions including cytokins in patients bitten by Bothrops spp. and Crotalus durissus terrificus in Brazil,” Journal of Venomous Animals and Toxins, vol. 1, pp. 11–22, 1995.
  20. H. Breithaupt, “Neurotoxic and myotoxic effects of Crotalus phospholipase A and its complex with crotapotin,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 292, no. 3, pp. 271–278, 1976. View at Scopus
  21. C. Montecucco, J. M. Gutiérrez, and B. Lomonte, “Cellular pathology induced by snake venom phospholipase A2 myotoxins and neurotoxins: common aspects of their mechanisms of action,” Cellular and Molecular Life Sciences, vol. 65, no. 18, pp. 2897–2912, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. C. Chang and J. D. Lee, “Crotoxin, the neurotoxin of South American rattlesnake venom, is a presynaptic toxin acting like β bungarotoxin,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 296, no. 2, pp. 159–168, 1977. View at Scopus
  23. L. Rodrigues-Simioni, B. J. Hawgood, and I. C. H. Smith, “Properties of the early phases of crotoxin poisoning at frog neuromuscular junctions,” Toxicon, vol. 28, no. 12, pp. 1479–1489, 1990. View at Publisher · View at Google Scholar · View at Scopus
  24. O. V. Brazil, “Neurotoxins from the South American rattle snake venom,” The Journal of the Formosan Medical Association, vol. 71, no. 6, pp. 394–400, 1972.
  25. A. L. Cecchini, A. M. Soares, J. R. Giglio, S. Amara, and E. C. Arantes, “Inhibition of L-glutamate and GABA synaptosome uptake by crotoxin, the major neurotoxin from Crotalus durissus terrificus venom,” Journal of Venomous Animals and Toxins including Tropical Diseases, vol. 10, pp. 260–279, 2004.
  26. C. L. Ownby, “Structure, function and biophysical aspects of the myotoxins from snake venoms,” Journal of Toxicology, vol. 17, no. 2, pp. 213–238, 1998. View at Scopus
  27. O. Vital Brazil and M. D. Fontana, “Toxins as tools in the study of sodium channel distribution in the muscle fibre membrane,” Toxicon, vol. 31, no. 9, pp. 1085–1098, 1993. View at Publisher · View at Google Scholar · View at Scopus
  28. P. F. Worley and J. M. Baraban, “Site of anticonvulsant action on sodium channels: autoradiographic and electrophysiological studies in rat brain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 9, pp. 3051–3055, 1987.
  29. W. B. Mors, M. C. do Nascimento, B. M. Ruppelt Pereira, and N. Alvares Pereira, “Plant natural products active against snake bite—the molecular approach,” Phytochemistry, vol. 55, no. 6, pp. 627–642, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. S. R. Fattepur and S. P. Gawade, “Preliminary screening of herbal plant extracts for antivenom activity against common sea snake (Enhydrina schistosa) poisoning,” Pharmacognosy Magazine, vol. 3, no. 9, pp. 56–60, 2007.
  31. M. L. Santos, C. V. Iglesias, M. H. Toyama, and R. Aparicio, “Structural studies of snake venom PLA2 in the presence of flavonoids,” LNS Activity Report 1-2, 2006.
  32. I. U. Asuzu and A. L. Harvey, “The antisnake venom activities of Parkia biglobosa (Mimosaceae) stem bark extract,” Toxicon, vol. 42, no. 7, pp. 763–768, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. A. V. Colares, M. G. dos Santos, A. P. Corrado et al., “The antiophydic activities of the hydroalcoholic extract from the leaves of Galactia glaucescens (Kunth) Leguminosacea,” ANM Journal, vol. 180, pp. 16–25, 2010.
  34. F. Dajas, A. Rivera-Megret, F. Blasina et al., “Neuroprotection by flavonoids,” Brazilian Journal of Medical and Biological Research, vol. 36, no. 12, pp. 1613–1620, 2003. View at Scopus
  35. M. Mishina, T. Takai, K. Imoto et al., “Molecular distinction between fetal and adult forms of muscle acetylcholine receptor,” Nature, vol. 321, pp. 406–411, 1986. View at Publisher · View at Google Scholar · View at Scopus
  36. B. H. Lee, T. J. Shin, S. H. Hwang et al., “Inhibitory effects of quercetin on muscle-type of nicotinic acetylcholine receptor-mediated ion currents expressed in Xenopus oocytes,” Korean Journal of Physiology and Pharmacology, vol. 15, no. 4, pp. 195–201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Bon, J. P. Changeux, T. W. Jeng, and H. Fraenkel-Conrat, “Postsynaptic effects of crotoxin and of its isolated subunits,” European Journal of Biochemistry, vol. 99, no. 3, pp. 471–481, 1979. View at Scopus
  38. B. Silva, P. J. Oliveira, A. Dias, and J. O. Malva, “Quercetin, kaempferol and biapigenin from Hypericum perforatum are neuroprotective against excitotoxic insults,” Neurotoxicity Research, vol. 13, no. 3-4, pp. 265–279, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Roghani, M. Reza, V. Mahdavi, and T. Baluchnejadmojarad, “The effect of the bioflavonoid quercetin on voltage-gated calcium channels in Periplaneta americana Df motoneuron,” Journal of Medicinal Plants Research, vol. 6, pp. 1279–1283, 2012.
  40. Y. Yao, D. D. Han, T. Zhang, and Z. Yang, “Quercetin improves cognitive deficits in rats with chronic cerebral ischemia and inhibits voltage-dependent sodium channels in hippocampal CA1 pyramidal neurons,” Phytotherapy Research, vol. 24, no. 1, pp. 136–140, 2010. View at Publisher · View at Google Scholar · View at Scopus